AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 72,300 shares, a growth of 5.1% from the August 15th total of 68,800 shares. Based on an average daily trading volume, of 23,800 shares, the days-to-cover ratio is presently 3.0 days. Currently, 2.0% of the company’s shares are short sold.

AquaBounty Technologies Stock Up 5.1 %

Shares of NASDAQ AQB opened at $1.23 on Wednesday. The company has a 50 day simple moving average of $1.31 and a 200 day simple moving average of $1.68. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.96 and a quick ratio of 1.96. AquaBounty Technologies has a 1 year low of $0.81 and a 1 year high of $6.13. The firm has a market cap of $4.74 million, a PE ratio of -0.14 and a beta of 1.14.

AquaBounty Technologies (NASDAQ:AQB) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($1.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.93) by ($0.63). The business had revenue of $0.18 million for the quarter, compared to the consensus estimate of $0.10 million. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. On average, research analysts forecast that AquaBounty Technologies will post -4.86 EPS for the current year.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.